Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisone with Antihistamines for Acute Urticaria
NCT02565680Phase 3Completed
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Feb 2012
- Primary completion
- Feb 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute urticaria comparing Prednisone + Levocetirizine with Placebo + Levocetirizine (2 arms). Primary endpoint: Resolution of Acute Urticaria at 48 hours. Started Feb 2012; status: completed.
02
Drugs
prednisone
03
Conditions
acute urticaria
Beyond the preview
Go deeper on NCT02565680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02565680.